Boston Scientific/Guidant Recalls Additional Defibrillators
Boston Scientific/Guidant and the FDA announced today that a subset of cardiac defibrillators within the Contak Renewal 3 & 4, Vitality and Vitality 2 families have been recalled. The recall includes about 73,000 implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators because of faulty capacitors that may cause depletion of the batteries sooner than would normally be expected.
Continue reading "Boston Scientific/Guidant Recalls Additional Defibrillators" »
